Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Buy
60
CELJF Quote, Financials, Valuation and Earnings
Last price:
$5.47
Seasonality move
:
-10.65%
Day range:
$5.40 - $5.47
52-week range:
$3.10 - $5.70
Dividend yield:
0%
P/E ratio:
22.43x
P/S ratio:
0.76x
P/B ratio:
1.40x
Volume:
325
Avg. volume:
729
1-year change:
32.38%
Market cap:
$906M
Revenue:
$1.2B
EPS (TTM):
$0.24
Analysts' Opinion
-
Consensus RatingCellcom Israel has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Cellcom Israel has an estimated downside of -- from its current price of $5.47.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $5.47.
Fair Value
-
According to the consensus of 0 analysts, Cellcom Israel has -- downside to fair value with a price target of -- per share.
CELJF vs. S&P 500
-
Over the past 5 trading days, Cellcom Israel has underperformed the S&P 500 by -4.04% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Cellcom Israel does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Cellcom Israel has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Cellcom Israel reported revenues of $301.2M.
Earnings Growth
-
Cellcom Israel has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Cellcom Israel reported earnings per share of $0.09.
Enterprise value:
1.4B
EV / Invested capital:
1.17x
Price / LTM sales:
0.76x
EV / EBIT:
15.47x
EV / Revenue:
1.15x
PEG ratio (5yr expected):
--
EV / Free cash flow:
9.41x
Price / Operating cash flow:
6.28x
Enterprise value / EBITDA:
4.08x
Gross Profit (TTM):
$368M
Return On Assets:
2.28%
Net Income Margin (TTM):
3.36%
Return On Equity:
6.52%
Return On Invested Capital:
3.29%
Operating Margin:
8.51%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $1.6B | $1.2B | $1.2B | $300.9M | $301.2M | |
| Gross Profit | $520.9M | $373M | $368M | $96.8M | $96.9M | |
| Operating Income | $151.9M | $97M | $90.1M | $27.3M | $25.6M | |
| EBITDA | $363.9M | $340.1M | $337.8M | $89.9M | $94.7M | |
| Diluted EPS | $0.23 | $0.25 | $0.24 | $0.09 | $0.09 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $553.5M | $530.6M | $564.1M | $404.4M | $356.8M | |
| Total Assets | $2B | $2B | $1.9B | $1.7B | $1.7B | |
| Current Liabilities | $509.1M | $504.8M | $538.3M | $502.2M | $545M | |
| Total Liabilities | $1.4B | $1.4B | $1.4B | $1.1B | $1.1B | |
| Total Equity | $556.7M | $591.5M | $574.8M | $584.4M | $647.8M | |
| Total Debt | $874.2M | $853.9M | $811.9M | $612.3M | $527.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $346.8M | $320.3M | $316.1M | $73.9M | $86.8M | |
| Cash From Investing | -$237M | -$139.7M | -$165.5M | $9.8M | -$44.8M | |
| Cash From Financing | -$77.5M | -$256.9M | -$205.8M | -$129M | -$134.7M | |
| Free Cash Flow | $141.8M | $143.7M | $146.5M | $34.5M | $41.5M | |
CELJF
Sector
Market Cap
$906M
$112.9M
Price % of 52-Week High
95.92%
65.22%
Dividend Yield
0%
0%
Shareholder Yield
--
3.48%
1-Year Price Total Return
32.38%
-17.6%
Beta (5-Year)
1.009
0.704
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$5.58
200-day SMA
Buy
Level
$4.20
Bollinger Bands (100)
Buy
Level
3.95 - 5.03
Chaikin Money Flow
Sell
Level
-3.9M
20-day SMA
Buy
Level
$5.35
Relative Strength Index (RSI14)
Buy
Level
64.10
ADX Line
Sell
Level
19.93
Williams %R
Neutral
Level
-43.1111
50-day SMA
Buy
Level
$4.90
MACD (12, 26)
Buy
Level
0.20
25-day Aroon Oscillator
Buy
Level
28
On Balance Volume
Neutral
Level
9.9M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.3894)
Sell
CA Score
(Annual)
Level (-0.8283)
Buy
Beneish M-Score
(Annual)
Level (-3.1314)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (1.211)
Buy
Piotroski F Score
(Annual)
Level (6)
Sell
Quality Ratio Score
Level (4)
Sell
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Cellcom Israel Ltd is the largest wireless provider in Israel and holds about one third of the market. The company offers basic voice services and data services such as Web browsing and music downloads. Cellcom is also launching a next-generation wireless service that supports higher data capacity. The company went public in February 2007, and its largest shareholder, Discount Investment, owns about 47% of its shares.
Stock Forecast FAQ
In the current month, CELJF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CELJF average analyst price target in the past 3 months is --.
-
Where Will Cellcom Israel Stock Be In 1 Year?
According to analysts, the consensus estimate is that Cellcom Israel share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Cellcom Israel?
Analysts are divided on their view about Cellcom Israel share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cellcom Israel is a Sell and believe this share price will rise from its current level to --.
-
What Is Cellcom Israel's Price Target?
The price target for Cellcom Israel over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CELJF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Cellcom Israel is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CELJF?
You can purchase shares of Cellcom Israel via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cellcom Israel shares.
-
What Is The Cellcom Israel Share Price Today?
Cellcom Israel was last trading at $5.47 per share. This represents the most recent stock quote for Cellcom Israel. Yesterday, Cellcom Israel closed at $5.47 per share.
-
How To Buy Cellcom Israel Stock Online?
In order to purchase Cellcom Israel stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Sell
40
MSTR alert for Dec 24
MicroStrategy [MSTR] is up 8.05% over the past day.
Sell
26
NUTX alert for Dec 24
Nutex Health [NUTX] is down 0.76% over the past day.
Sell
48
VRNA alert for Dec 24
Verona Pharma PLC [VRNA] is down 0.4% over the past day.
